[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …

JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Licensed pertussis vaccines in the United States: history and current state

NP Klein - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
The United States switched from whole cell to acellular pertussis vaccines in the 1990s
following global concerns with the safety of the whole cell vaccines. Despite high levels of …

[HTML][HTML] Combination vaccines

DAG Skibinski, BC Baudner, M Singh… - Journal of global …, 2011 - journals.lww.com
The combination of diphtheria, tetanus, and pertussis vaccines into a single product has
been central to the protection of the pediatric population over the past 50 years. The addition …

New combination vaccines: DTaP-IPV (kinrix) and DTaP-IPV/Hib (pentacel)

TL Johns, GE Hutter - Annals of Pharmacotherapy, 2010 - journals.sagepub.com
Objective: To evaluate the clinical utility of diphtheria and tetanus toxoids and acellular
pertussis adsorbed and inactivated poliovirus vaccine ([DTaP-IPV]; Kinrix) and diphtheria …

[HTML][HTML] Estimating the total societal cost of a hexavalent vaccine versus a pentavalent vaccine with hepatitis B in South Korea

S Min, SH Kwon, YW Lee, JM Lee, EJ Bae, EK Lee - Vaccines, 2023 - mdpi.com
In South Korea, the ready-to-use hexavalent vaccine (against diphtheria, tetanus, pertussis,
poliovirus, Haemophilus influenzae type b, and hepatitis B) is not listed despite its facility of …

An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella …

NP Klein, WM Weston, S Kuriyakose, D Kolhe, B Howe… - Vaccine, 2012 - Elsevier
BACKGROUND: In the US, it is recommended that 4–6 year old children receive diphtheria–
tetanus–acellular pertussis (DTaP), inactivated poliovirus (IPV), measles–mumps–rubella …

Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine

M Sun, Y Ma, Y Xu, H Yang, L Shi, Y Che, G Liao… - Vaccine, 2014 - Elsevier
Abstract The World Health Organization has recommended that a Sabin inactivated polio
vaccine (IPV) should gradually and synchronously replace oral polio vaccines for routine …

[HTML][HTML] Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model

X Wang, N Gao, J Wen, J Li, Y Ma, M Sun, J Liang… - Vaccines, 2021 - mdpi.com
The research and development of a pertussis-combined vaccine using a novel inactivated
poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio …

[HTML][HTML] Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine …

SM Lee, SJ Kim, J Chen, JH Kim… - Human Vaccines & …, 2019 - Taylor & Francis
ABSTRACT Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …

Immunogenicity, reactogenicity and safety of a combined DTPa-IPV vaccine compared with separate DTPa and IPV vaccines in healthy Korean infants

CH Kim, SH Cha, SM Shin, CS Kim… - Korean Journal of …, 2010 - synapse.koreamed.org
Purpose To compare immunogenicity and reactogenicity of a combined diphtheria-tetanus-
acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV, Infanrix™ IPV …